TY - JOUR
T1 - Trends in Prehospital Pain Management
T2 - Two Decades of Point-of-Injury Care
AU - Nakar, Helit
AU - Sorkin, Alex
AU - Nadler, Roy
AU - Tsur, Avishai M.
AU - Gelikas, Shaul
AU - Avital, Guy
AU - Glassberg, Elon
AU - Bader, Tarif
AU - Fridrich, Lidar
AU - Chen, Jacob
AU - Benov, Avi
N1 - Publisher Copyright:
© 2022 Israel Medical Association. All rights reserved.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Background: Pain control in trauma is an integral part of treatment in combat casualty care. More soldiers injured on the battlefield need analgesics for pain than life-saving interventions (LSIs). Early treatment of pain improves outcomes after injury, while inadequate treatment leads to higher rates of post-traumatic stress disorder (PTSD). Objectives: To describe the experience of the Israel Defense Forces (IDF) Medical Corps with prehospital use of analgesia. Methods: All cases documented in the IDF-Trauma Registry between January 1997 and December 2019 were examined. Data collection included analgesia administered, mechanism of injury, wound distribution, and life-saving interventions performed. Results: Of 16,117 patients, 1807 (11.2%) had at least one documented analgesia. Demographics included 91.2% male; median age 21 years. Leading mechanism of injury was penetrating (52.9%). Of injured body regions reported, 46.2% were lower extremity wounds. Most common types of analgesics were morphine (57.2%) and fentanyl (27%). Over the two decades of the study period, types of analgesics given by providers at point of injury (POI) had changed. Fentanyl was introduced in 2013, and by 2019 was given to 39% of patients. Another change was an increase of casualties receiving analgesia from 5–10% until 2010 to 34% by 2019. A total of 824 LSIs were performed on 556 patients (30.8%) receiving analgesia and no adverse events were found in any of the casualties. Conclusions: Most casualties at POI did not receive any analgesics. The most common analgesics administered were opioids. Over time analgesic administration has gained acceptance and become more commonplace on the battlefield.
AB - Background: Pain control in trauma is an integral part of treatment in combat casualty care. More soldiers injured on the battlefield need analgesics for pain than life-saving interventions (LSIs). Early treatment of pain improves outcomes after injury, while inadequate treatment leads to higher rates of post-traumatic stress disorder (PTSD). Objectives: To describe the experience of the Israel Defense Forces (IDF) Medical Corps with prehospital use of analgesia. Methods: All cases documented in the IDF-Trauma Registry between January 1997 and December 2019 were examined. Data collection included analgesia administered, mechanism of injury, wound distribution, and life-saving interventions performed. Results: Of 16,117 patients, 1807 (11.2%) had at least one documented analgesia. Demographics included 91.2% male; median age 21 years. Leading mechanism of injury was penetrating (52.9%). Of injured body regions reported, 46.2% were lower extremity wounds. Most common types of analgesics were morphine (57.2%) and fentanyl (27%). Over the two decades of the study period, types of analgesics given by providers at point of injury (POI) had changed. Fentanyl was introduced in 2013, and by 2019 was given to 39% of patients. Another change was an increase of casualties receiving analgesia from 5–10% until 2010 to 34% by 2019. A total of 824 LSIs were performed on 556 patients (30.8%) receiving analgesia and no adverse events were found in any of the casualties. Conclusions: Most casualties at POI did not receive any analgesics. The most common analgesics administered were opioids. Over time analgesic administration has gained acceptance and become more commonplace on the battlefield.
KW - analgesia
KW - pain management
KW - trauma
KW - trends
UR - http://www.scopus.com/inward/record.url?scp=85138848046&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36168177
AN - SCOPUS:85138848046
SN - 1565-1088
VL - 24
SP - 584
EP - 590
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 9
ER -